1479. Evaluating the Impact of Procalcitonin on Antibiotic Utilization in Chronic Obstructive Pulmonary Disease Exacerbations

BACKGROUND: Antibiotic prescription rates for treating exacerbations of chronic obstructive pulmonary disease (COPD) have been reported as high as 90% in the United States. Research has shown that over 50% of COPD exacerbations are due to viral etiologies. Elevations in procalcitonin (PCT) levels ca...

Descripción completa

Detalles Bibliográficos
Autores principales: Lin, Kevin, Dempsey, Casey, Patel, Shivani, Butler, John, Septimus, Edward
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2018
Materias:
Abstracts
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6252594/
http://dx.doi.org/10.1093/ofid/ofy210.1308

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6252594/
http://dx.doi.org/10.1093/ofid/ofy210.1308

Ejemplares similares